This paper is in the following e-collection/theme issue:

Development of Novel Medical Devices and Innovations for Existing Devices (83) Innovations and Technology in Cancer Care (431)

Published on in Vol 7, No 1 (2022): Jan-Jun

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/35346, first published .
The Cole Relaxation Frequency as a Parameter to Identify Cancer in Lung Tissue: Preliminary Animal and Ex Vivo Patient Studies

The Cole Relaxation Frequency as a Parameter to Identify Cancer in Lung Tissue: Preliminary Animal and Ex Vivo Patient Studies

The Cole Relaxation Frequency as a Parameter to Identify Cancer in Lung Tissue: Preliminary Animal and Ex Vivo Patient Studies

Authors of this article:

Les Bogdanowicz1, 2 Author Orcid Image ;   Onur Fidaner1 Author Orcid Image ;   Donato Ceres1 Author Orcid Image ;   Alexander Grycuk1 Author Orcid Image ;   Martina Guidetti1 Author Orcid Image ;   David Demos3, 4 Author Orcid Image
Article Authors Cited by Tweetations (2) Metrics

Les Bogdanowicz   1, 2 , PhD ;   Onur Fidaner   1 , PhD ;   Donato Ceres   1 , PhD ;   Alexander Grycuk   1 , BS ;   Martina Guidetti   1 , PhD ;   David Demos   3, 4 , MD

1 Novascan Inc, Chicago, IL, United States

2 Department of Biomedical Engineering, University of Illinois at Chicago, Chicago, IL, United States

3 Aurora St. Luke’s Medical Center, Milwaukee, WI, United States

4 Department of Cardiothoracic Surgery, Aurora Healthcare, Milwaukee, WI, United States

Corresponding Author: